Sviluppo di un modello in vitro tridimensionale basato sull’impiego di substrati biologici applicati allo studio di patologie tumorali in medicina umana e veterinaria

Title

Code

MET ALT

Type

Sperimentale

Start Year

2022

Status

In Corso

Principal Investigator

+39-051-6366595

enrico.lucarelli@ior.it

Lucarelli Enrico, PhD

Head

Regenerative Therapies in Oncology (TRO)

Operational unit that carry out the study

simple unit

Terapie Rigenerative in Oncologia (TRO)

Head

Lucarelli Enrico, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. MET ALT

Wednesday 12 October 2022, 16:31

PG0015066_2022_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Sviluppo di un modello in vitro tridimensionale basato sull’impiego di substrati biologici applicati allo studio di patologie tumorali in medicina umana e veterinaria

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Sviluppo di un modello in vitro tridimensionale basato sull’impiego di substrati biologici applicati allo studio di patologie tumorali in medicina umana e veterinaria

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in